The Covid-19 pandemic is an unprecedented public health and economic shock. We can confidently say that the “new normal”, when it emerges, includes a deep recession and an acute capacity crisis in healthcare systems worldwide. How long they will last and how deep will be the effects, we don’t yet know.
Recent history, especially the 2008 financial crisis, has shown that – even in highly uncertain times – companies can react with a longer-term view to defend share or even achieve continued growth. Our presentation at the 2020 Eyeforpharma virtual conference looks at pertinent case studies to understand what Life Sciences companies have done and identify choices and strategies that proved successful.